Bank of America’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Sell |
19,216
-25,810
| -57% | -$50.3K | ﹤0.01% | 5886 |
|
|
2025
Q1 | $98.6K | Buy |
45,026
+40,517
| +899% | +$88.7K | ﹤0.01% | 5506 |
|
|
2024
Q4 | $14.7K | Buy |
4,509
+4,456
| +8,408% | +$14.5K | ﹤0.01% | 6002 |
|
|
2024
Q3 | $69 | Buy |
53
+11
| +26% | +$14 | ﹤0.01% | 6851 |
|
|
2024
Q2 | $51 | Buy |
+42
| New | +$51 | ﹤0.01% | 6937 |
|
|
2024
Q1 | – | Sell |
-62
| Closed | -$79 | – | 6913 |
|
|
2023
Q4 | $79 | Buy |
+62
| New | +$79 | ﹤0.01% | 6471 |
|
|
2023
Q1 | – | Sell |
-7
| Closed | -$20 | – | 7078 |
|
|
2022
Q4 | $20 | Buy |
+7
| New | +$20 | ﹤0.01% | 7161 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | – | – | 7536 |
|
|
2021
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 7429 |
|